Jung Park
Family · Los Angeles, CANPI 1275118119
Payments from drug & device makers
Across 63 payments — averaging $21.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$296
- GSK$199
- Novo Nordisk$146
- Lilly USA, LLC$113
- Ironwood Pharmaceuticals, Inc$80
- Amarin Pharma, Inc.$70
- plus $470 from 14 others
What the payments were for
- Food & beverage$1,376100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $296 |
| GSK | 12 | $199 |
| Novo Nordisk | 7 | $146 |
| Lilly USA, LLC | 5 | $113 |
| Ironwood Pharmaceuticals, Inc | 4 | $80 |
| Amarin Pharma, Inc. | 3 | $70 |
| Merck | 3 | $64 |
| Boehringer Ingelheim | 2 | $59 |
| Bayer | 3 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Genentech USA, Inc. | 2 | $39 |
| Baxter Healthcare | 1 | $36 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Nestle Healthcare Nutrition Inc. | 1 | $25 |
| Amgen | 1 | $22 |
| Ardelyx, Inc. | 1 | $22 |
| AstraZeneca | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Vivus LLC | 1 | $19 |
| Eyevance Pharmaceuticals LLC | 1 | $14 |
How this compares
$1,376 in reported general payments places this provider in the 80th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 17 | $16,196 |
| VascepaIcosapent Ethyl | 18 | $9,466 |
| Lidocaine | 11 | $1,448 |
| Oseltamivir Phosphate | 14 | $289 |
| Losartan Potassium | 26 | $167 |
| Levothyroxine Sodium | 12 | $156 |
| Triamcinolone Acetonide | 28 | $133 |
| Atorvastatin Calcium | 33 | $123 |
| Amlodipine Besylate | 37 | $99 |
| Metoprolol Succinate | 11 | $83 |
| Tamsulosin Hcl | 14 | $82 |
| Pantoprazole Sodium | 19 | $79 |
| Rosuvastatin Calcium | 13 | $76 |
| Donepezil Hcl | 11 | $51 |
| Simvastatin | 21 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $296 | $16,19617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,634 family providers in California.
Other family in Los Angeles
- Annette ShonLos Angeles$406K
- Phyllis CasonLos Angeles$187K
- Theodore SolomonLos Angeles$131K
- Angela SarffLos Angeles$51K
- Karla MenjivarLos Angeles$36K
- Janet GripshoverLos Angeles$30K
- Jualynda SmithLos Angeles$28K
- Phoebedel ReyesLos Angeles$26K
- Lori RobertsonChino Hills$475K
- Nancy GardettoSan Diego$394K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.